SuperworthPasithea Therapeutics market cap KTTA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $13.5M
- Highest close in our data
- $53M
- Nov 2021
Pasithea Therapeutics is worth $13.5M at the close on Oct 23, 2026, at $0.40 a share.
That is up 153% over the last year and down 57% over five years.
Its highest close in our data was $53M in Nov 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $13.5M | $5.3M | $23.9M | +62% |
| 2025 | $8.3M | $1.4M | $10.9M | +141% |
| 2024 | $3.5M | $3.3M | $8.9M | −55% |
| 2023 | $7.7M | $6.3M | $20.4M | −59% |
| 2022 | $18.8M | $13.5M | $35.6M | −20% |
| 2021 | $23.4M | $19.5M | $53M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Pasithea Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| KTTAPasithea Therapeutics | $13.5M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Pasithea Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.